Literature DB >> 17674972

A single Gly114Arg mutation stabilizes the hexameric subunit assembly and changes the substrate specificity of halo-archaeal nucleoside diphosphate kinase.

Matsujiro Ishibashi1, Shuhei Tatsuda, Ken-ichi Izutsu, Kouko Kumeda, Tsutomu Arakawa, Masao Tokunaga.   

Abstract

Nucleoside diphosphate kinase from extremely halophilic archaeon (HsNDK) requires above 2M NaCl concentration for in vitro refolding. Here an attempt was made to isolate mutations that allow HsNDK to refold in low salt media. Such a screening resulted in isolation of an HsNDK mutant, Gly114Arg, which efficiently refolded in the presence of 1M NaCl. This mutant, unlike the wild type enzyme, was expressed in Escherichia coli as an active form. The residue 114 is in close proximity to Glu155 of the neighboring subunit in the three dimensional hexameric structure of the HsNDK. It is thus possible that the attractive electrostatic interactions occur between Arg114 and Glu155 in the mutant HsNDK, stabilizing the hexameric subunit assembly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674972     DOI: 10.1016/j.febslet.2007.07.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Molecular mechanism of distinct salt-dependent enzyme activity of two halophilic nucleoside diphosphate kinases.

Authors:  Akihiro Yamamura; Takefumi Ichimura; Masahiro Kamekura; Toru Mizuki; Ron Usami; Tsukasa Makino; Jun Ohtsuka; Ken-ichi Miyazono; Masahiko Okai; Koji Nagata; Masaru Tanokura
Journal:  Biophys J       Date:  2009-06-03       Impact factor: 4.033

2.  Increase of salt dependence of halophilic nucleoside diphosphate kinase caused by a single amino acid substitution.

Authors:  Matsujiro Ishibashi; Tomoe Hayashi; Chiho Yoshida; Masao Tokunaga
Journal:  Extremophiles       Date:  2013-04-23       Impact factor: 2.395

3.  Dissecting the unique nucleotide specificity of mimivirus nucleoside diphosphate kinase.

Authors:  Sandra Jeudy; Audrey Lartigue; Jean-Michel Claverie; Chantal Abergel
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.